The Indus Hospital Blood Center now complies with Federal Drug Association (FDA, USA) requirement for Donor Screening | Indus Hospital & Health Network

The Indus Hospital Blood Center now complies with Federal Drug Association (FDA, USA) requirement for Donor Screening

Since April 2018, Nucleic Acid Testing (NAT) using Polymerase Chain Reaction (PCR) technology is being used for identifying Hepatitis B and Hepatitis C viruses on every single donor in addition to CLIA which was already being performed. Thus fulfilling FDA (USA) requirement for donor screening.

16 Comments

  • Gotune 50mm delik acmaya geliyorum ammina kodugum

    ZZZ October 26, 2019
  • Gotune 50mm delik acmaya geliyorum ammina kodugum

    ZZZ October 26, 2019
  • Seo hit, backlink, hacklink vb. data arşivi

    googleseo December 27, 2019

Leave a comment

Your email address will not be published.

5 × 2 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Thanks!